Related Experiment Video
Updated: Aug 30, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Compliance and the therapeutic effect in patients with arterial hypertension
H Horvathova1, K Kimlikova, I Balazovjech
1IInd Department of Internal Medicine, University Hospital, Comenius University, Bratislava, Slovakia. henrieta.horvathova@yahoo.com
Insights
Patient compliance significantly impacts hypertension treatment outcomes. Improving patient cooperation and adherence to medication and lifestyle changes is crucial for effective blood pressure control and preventing complications.
Area of Science:
- Cardiology
- Public Health
Background:
- Essential hypertension management requires understanding treatment efficacy and patient adherence.
- Hypertension outpatient departments monitor patient progress and treatment effectiveness.
Purpose of the Study:
- To analyze the therapeutic effect of hypertension treatment.
- To evaluate the influence of patient cooperation on treatment effectiveness.
- To assess the impact of adherence on blood pressure reduction.
Main Methods:
- Retrospective analysis of medical records for 101 essential hypertension patients.
- Evaluation of treatment effectiveness and patient compliance using questionnaires.
- Monitoring blood pressure changes and adherence to medication and lifestyle modifications.
Main Results:
- Pharmacological treatment normalized blood pressure in 28% of patients, with a statistically significant drop from 146/90 mmHg to 129/82 mmHg.
- Only 7% of patients demonstrated full compliance; compliant patients showed more marked blood pressure reduction.
- Low patient compliance was observed for non-medicamentous treatments, including salt intake reduction, smoking cessation, and weight reduction.
Conclusions:
- Treatment for arterial hypertension is often insufficient, with better outcomes in earlier stages.
- A significant percentage of patients exhibit non-compliance, negatively affecting blood pressure control.
- Patient compliance is positively correlated with blood pressure reduction, emphasizing the need for regular monitoring and patient motivation for long-term management and complication prevention.
Objective And Method:
To analyse the therapeutic effect of treatment in patients monitored in our hypertension outpatient department and evaluation using questionnaires. To determine the influence of treatment effectiveness on the level of co-operation received from the patient. The effect of treatment was monitored by retrospective analysis of the medical records of 101 patients with essential hypertension.
Results:
1) Pharmacological treatment of essential hypertension led to the normalisation of blood pressure levels in 28 patients. The drop in pressure from 146/90 mmHg to 129/82 mmHg was statistically significant (p = 0.001). 2) Only 7 % of patients were fully compliant. A drop (6) in blood pressure was more marked in compliant patients (deltaBPs = 11 mmHg, deltaBPd=9 mmHg), compared with the group of non-compliant patients (deltaBPs = 3 mmHg, deltaBPd = -4 mmHg). 3) Patients have a low level of compliance in relation to non-medicamentous treatment. They are not willing to cut down their salt intake (37%), to stop smoking (12 %) and to reduce their weight (11%).
Conclusion:
The conducted study confirms the insufficient treatment of arterial hypertension, a better effect of treatment in the patients with 1st stage of arterial hypertension compared with the patients with a more serious stages, a fairly high percentage of non-compliant patients and a positive connection between patient's compliance and the reduction in blood pressure values. We would like to emphasise that long-term compensation of blood pressure is a key factor in preventing complications. The efficiency of treatment depends on regular blood pressure controls and intensive motivation of the patient to respect the therapeutic discipline. (Tab. 9, Fig. 1, Ref. 17.)
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension V: Nursing Management
Drug Therapy
Antianxiety Medications